Bhojpuri actor Pawan Singh’s ex Akshara Singh backs wife Jyoti Singh’s alimony demand, adding a new twist to their ongoing marital dispute.

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

Novo Nordisk said it will take legal action again telehealth provider Hims & Hers after Hims announced a cheaper copycat version of Novo's Wegovy weight loss pill. Hims said it would sell a copy of ...

Novo Nordisk has launched its Wegovy GLP-1 drug in pill form. Amazon is getting into the fight, offering ease and low costs to customers who buy the Wegovy pill on its platform. Up until 2026, GLP-1 ...

Novo shares rise 5% after Hims scraps $49 weight‑loss pill FDA signals broader crackdown on compounded GLP-1 drugs Hims pulled its semaglutide-based pill after pushback Hims says lawsuit attacks ...

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal. By Rebecca Robbins Hims & Hers, a major online provider of obesity medications, said ...

Share on Pinterest Hims & Hers has withdrawn its low cost compounded weight loss pill after pressure from top U.S. health officials and a major lawsuit. Image courtesy of Novo Nordisk Hims & Hers ...

FDA on Friday said it would restrict GLP-1 ingredients Novo, Lilly shares fell after Hims launched the pill on Thursday Hims said the decision followed discussions with stakeholders "Since launching ...

Hims & Hers Health launched a cheaper, compounded version of the new Wegovy pill in a move that reignites its competition with Novo Nordisk in the U.S. obesity-drug market. Shares of of Hims & Hers ...

A month after drugmaker Novo Nordisk launched its Wegovy pill, online health and wellness company Hims & Hers plans to undercut it with a compounded semaglutide pill offered at a lower price. Hims & ...

While there are plenty of foods and some health conditions that cause constipation, certain supplements may also be to blame. It’s worth double-checking your routine vitamins to see if they may be the ...

For the last year, any discussion of the obesity-drug market has come with an asterisk: Everything will change once pill versions of the popular GLP-1 drugs arrive. Those potentially cheaper ...